Alpha 1 -antitrypsin deficiency e Diagnostic testing and disease awareness in Germany

[1]  B. Dimitrov,et al.  The prevalence of alpha-1 antitrypsin deficiency in Ireland , 2011, Respiratory research.

[2]  T. Welte,et al.  Diagnostic delay and clinical modifiers in alpha-1 antitrypsin deficiency , 2010, Therapeutic advances in respiratory disease.

[3]  F. Huber,et al.  Alpha1-Antitrypsin-Mangel in Österreich: Auswertung der österreichischen Datenbank des internationalen Alpha1-Antitrypsin Registers , 2010, Wiener klinische Wochenschrift.

[4]  M. Miravitlles,et al.  Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres , 2010, European Respiratory Journal.

[5]  L. Fromer.  Improving Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in Primary Care: Translating Knowledge into Action , 2010, COPD.

[6]  J. Stoller,et al.  Knowledge of alpha-1 antitrypsin deficiency among internal medicine house officers and respiratory therapists: results of a survey. , 2010, Respiratory care.

[7]  R. Klitzman,et al.  Views of Discrimination among Individuals Confronting Genetic Disease , 2010, Journal of Genetic Counseling.

[8]  Edwin K Silverman,et al.  Clinical practice. Alpha1-antitrypsin deficiency. , 2009, New England Journal of Medicine.

[9]  R. Klitzman.  The impact of social contexts in testing for alpha-1 antitrypsin deficiency: the roles of physicians and others. , 2009, Genetic testing and molecular biomarkers.

[10]  R. Stockley,et al.  Augmentation Therapy for α1 Antitrypsin Deficiency: A Meta-Analysis , 2009, COPD.

[11]  T. Greulich,et al.  [The German registry of individuals with alpha-1-antitrypsin deficiency--a source for research on patient care]. , 2008, Pneumologie.

[12]  C. Strange,et al.  Primary care diagnosis of alpha-1 antitrypsin deficiency: issues and opportunities. , 2007, Cleveland Clinic journal of medicine.

[13]  C. Vogelmeier,et al.  Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program. , 2007, Respiratory medicine.

[14]  R. Stockley,et al.  Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development , 2007, European Respiratory Journal.

[15]  F. D. de Serres,et al.  Estimated numbers and prevalence of PI*S and PI*Z alleles of α1-antitrypsin deficiency in European countries , 2006, European Respiratory Journal.

[16]  C. Strange,et al.  Delay in Diagnosis of α1-Antitrypsin Deficiency: A Continuing Problem , 2005 .

[17]  M. Campos,et al.  Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003. , 2005, Chest.

[18]  C. Tinelli,et al.  Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency , 2005, Journal of Medical Genetics.

[19]  J. Stoller.  Erratum: ATS/ERS Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency (American Journal of Respiratory and Critical Care Medicine (835)) , 2004 .

[20]  F. Serres.  Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed. , 2003 .

[21]  Linda Casebeer,et al.  Designing tailored Web-based instruction to improve practicing physicians' chlamydial screening rates. , 2002, Academic medicine : journal of the Association of American Medical Colleges.

[22]  F. D. de Serres,et al.  Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. , 2002, Chest.

[23]  B. Balbi,et al.  A national program for detection of α1-antitrypsin deficiency in Italy , 1999 .

[24]  R. Buhl,et al.  Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group. , 1998, The European respiratory journal.

[25]  N. Banik,et al.  Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. , 1997, The European respiratory journal.

[26]  T. Mcneil,et al.  Primary prevention in a high‐risk group: smoking habits in adolescents with homozygous alpha‐1‐antitrypsin deficiency (ATD) , 1996, Acta paediatrica.

[27]  E. Piitulainen,et al.  Lung function in adolescents with α1‐antitrypsin deficiency , 1994, Acta paediatrica.

[28]  J. Hodge,et al.  Alpha1‐Antitrypsin Deficiency‐Associated Panniculitis: Case Report and Review of the Literature , 1991, Pediatric dermatology.

[29]  P. King,et al.  Severe deficiency of alpha 1-antitrypsin associated with cutaneous vasculitis, rapidly progressive glomerulonephritis, and colitis. , 1985, The American journal of medicine.

[30]  R. Crystal,et al.  Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. , 1981, The Journal of clinical investigation.

[31]  A. J. Chandrasekhar,et al.  Alpha1-antitrypsin deficiency with severe panniculitis. Report of two cases. , 1977, Annals of internal medicine.

[32]  T Sveger,et al.  Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. , 1976, The New England journal of medicine.